BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23888581)

  • 1. [Benzodiazepines : known risks and recent data].
    Cloos JM; Bocquet V
    Rev Med Liege; 2013; 68(5-6):303-10. PubMed ID: 23888581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study of patients with benzodiazepine dependence, hospitalised between 2006-2008].
    Străulea AO; Chiriţă V
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(1):89-92. PubMed ID: 21495303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders.
    Uhlenhuth EH; Balter MB; Ban TA; Yang K
    J Clin Psychopharmacol; 1999 Dec; 19(6 Suppl 2):23S-29S. PubMed ID: 10587281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thinking about stopping treatment for panic disorder.
    DuPont RL
    J Clin Psychiatry; 1990 Dec; 51 Suppl A():38-45. PubMed ID: 2258376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks associated with long-term benzodiazepine use.
    Johnson B; Streltzer J
    Am Fam Physician; 2013 Aug; 88(4):224-6. PubMed ID: 23944724
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence.
    Posternak MA; Mueller TI
    Am J Addict; 2001; 10(1):48-68. PubMed ID: 11268828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzodiazepines for anxiety disorders. Are the concerns justified?
    Rifkin A
    Postgrad Med; 1990 Jan; 87(1):209-11, 215-6, 219. PubMed ID: 2404265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating anxiety while minimizing abuse and dependence.
    Sussman N
    J Clin Psychiatry; 1993 May; 54 Suppl():44-51. PubMed ID: 8099577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Benefits and risks in using benzodiazepines from the viewpoint of pharmaco-epidemiology with reference to substance dependence].
    Ladewig D
    Schweiz Rundsch Med Prax; 1989 Jul; 78(27-28):773-8. PubMed ID: 2570452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders.
    Michelini S; Cassano GB; Frare F; Perugi G
    Pharmacopsychiatry; 1996 Jul; 29(4):127-34. PubMed ID: 8858711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawing Benzodiazepines in Patients With Anxiety Disorders.
    Lader M; Kyriacou A
    Curr Psychiatry Rep; 2016 Jan; 18(1):8. PubMed ID: 26733324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilizing benzodiazepines in clinical practice: an evidence-based discussion.
    J Clin Psychiatry; 2004 Nov; 65(11):1565-74. PubMed ID: 15554774
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of benzodiazepines on cognition.
    Stewart SA
    J Clin Psychiatry; 2005; 66 Suppl 2():9-13. PubMed ID: 15762814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes toward benzodiazepines over the years.
    Rosenbaum JF
    J Clin Psychiatry; 2005; 66 Suppl 2():4-8. PubMed ID: 15762813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The problems with the use of benzodiazepines in elderly patients].
    Bourin M
    Encephale; 2010 Sep; 36(4):340-7. PubMed ID: 20850606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Benzodiazepine therapy: an evaluation].
    Beckmann H; Haas S
    Nervenarzt; 1984 Mar; 55(3):111-21. PubMed ID: 6144052
    [No Abstract]   [Full Text] [Related]  

  • 17. [The withdrawal syndrome in benzodiazepine dependence and its management].
    Străulea AO; Chiriţă V
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):879-84. PubMed ID: 20191849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence on benzodiazepines.
    Lader M
    J Clin Psychiatry; 1983 Apr; 44(4):121-7. PubMed ID: 6131885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of GABAA receptor subtype selectivity to abuse liability and dependence potential of pharmacological treatments for anxiety and sleep disorders.
    Ator NA
    CNS Spectr; 2005 Jan; 10(1):31-9. PubMed ID: 15618945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzodiazepine use, abuse, and dependence.
    O'brien CP
    J Clin Psychiatry; 2005; 66 Suppl 2():28-33. PubMed ID: 15762817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.